Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease

ACS Nano

Volumn 6, Issue 7, 2012, Pages 5866-5879

  Le Droumaguet, Benjamin ^a   Nicolas, Julien ^a   Brambilla, Davide ^a   Mura, Simona ^a   Maksimenko, Andrei ^a   De Kimpe, Line ^b   Salvati, Elisa ^c   Zona, Cristiano ^c   Airoldi, Cristina ^c   Canovi, Mara ^d   Gobbi, Marco ^d   Magali, Noiray ^a   La Ferla, Barbara ^c   Nicotra, Francesco ^c   Scheper, Wiep ^b   Flores, Orfeu ^e   Masserini, Massimo ^c   Andrieux, Karine ^a   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e Stab Vida Madan Parque   (Portugal)

Author keywords

A peptide; Alzheimer's disease; cancer; nanoparticles; poly(alkyl cyanoacrylate); targeting

Indexed keywords

ALZHEIMER'S DISEASE; AMPHIPHILIC COPOLYMERS; AMYLOID PEPTIDES; AZIDE-ALKYNE CYCLOADDITION; BIOLOGICALLY ACTIVE LIGANDS; CANCER; CELL LINES; COCULTURE; COLLOIDAL STABILIZATION; COLLOIDAL SYSTEM; CONSTRUCTION METHOD; COVALENT LINKAGE; CURCUMIN DERIVATIVES; CYANOACRYLATES; FLUORESCENT PROPERTY; FUNCTIONALIZATIONS; FUNCTIONALIZED; HIGH AFFINITY; HUMAN BREAST CANCER; LUNG CARCINOMA; MOLAR RATIO; NANO PARTICULATES; NANOCARRIERS; OUTER SHELLS; POLYMER BACKBONES; POLYMERIC NANOPARTICLES; SURFACE FUNCTIONALIZATION; TARGETING; TOXIC SPECIES;

ACETYLENE; ADHESIVES; BIODEGRADABLE POLYMERS; CELL CULTURE; DISEASES; DRUG DELIVERY; DYES; NANOPARTICLES; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SELF ASSEMBLY;

LIGANDS;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); BIOTIN RECEPTOR; CYANOACRYLATE DERIVATIVE; DIAGNOSTIC AGENT; DRUG CARRIER; GROWTH FACTOR RECEPTOR; NANOPARTICLE; PEPTIDE FRAGMENT; POLYMER;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CHEMISTRY; COLLOID; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; MOUSE; NANOTECHNOLOGY; NEOPLASM; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE, TUMOR; COLLOIDS; CYANOACRYLATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICROSCOPY, CONFOCAL; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; PEPTIDE FRAGMENTS; POLYMERS; RECEPTORS, GROWTH FACTOR; SURFACE PLASMON RESONANCE;

EID: 84864210191     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn3004372     Document Type: Article

References (53)

1. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis Adv. Drug Delivery Rev. 2002, 54, 631-651 (Pubitemid 35247520)
2. Brambilla, D.; Le Droumaguet, B.; Nicolas, J.; Hashemi, S. H.; Wu, L.-P.; Moghimi, S. M.; Couvreur, P.; Andrieux, K. Nanotechnologies for Alzheimer's Disease: Therapy, Diagnosis and Safety Issues Nanomedicine: NBM 2011, 7, 521-540
3. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20
4. Sanhai, W. R.; Sakamoto, J. H.; Canady, R.; Ferrari, M. Seven Challenges for Nanomedicine Nat. Nanotechnol. 2008, 3, 242-244 (Pubitemid 351668048)
5. Erb, S. E. Nanotechnology in Drug Delivery Drug Delivery Syst. 2009, 24, 63-70
6. Riehemann, K.; Schneider, S. W.; Luger, T. A.; Godin, B.; Ferrari, M.; Fuchs, H. Nanomedicine-Challenge and Perspectives Angew. Chem., Int. Ed. 2009, 48, 872-897
7. Arias, J. L.; Reddy, L. H.; Othman, M.; Gillet, B.; Desmaële, D.; Zouhiri, F.; Dosio, F.; Gref, R.; Couvreur, P. Squalene Based Nanocomposites: A New Platform for the Design of Multifunctional Pharmaceutical Theragnostics ACS Nano 2011, 5, 1513-1521
8. Hans, M. L.; Lowman, A. M. Biodegradable Nanoparticles for Drug Delivery and Targeting Curr. Opin. Solid State Mater. Sci. 2002, 6, 319-327 (Pubitemid 36238389)
9. Panyam, J.; Labhasetwar, V. Biodegradable Nanoparticles for Drug and Gene Delivery to Cells and Tissue Adv. Drug Delivery Rev. 2003, 55, 329-347 (Pubitemid 36297053)
10. Brannon-Peppas, L. Recent Advances on the Use of Biodegradable Microparticles and Nanoparticles in Controlled Drug Delivery Int. J. Pharm. 1995, 116, 1-9
11. Sinha, R.; Kim, G. J.; Nie, S.; Shin, D. M. Nanotechnology in Cancer Therapeutics: Bioconjugated Nanoparticles for Drug Delivery Mol. Cancer Ther. 2006, 5, 1909-1917 (Pubitemid 44336561)
12. Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices J. Controlled Release 2001, 70, 1-20 (Pubitemid 32144788)
13. Cabral, H.; Nishiyama, N.; Kataoka, K. Supramolecular Nanodevices: From Design Validation to Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 999-1008
14. Couvreur, P.; Vauthier, C. Nanotechnology: Intelligent Design to Treat Complex Disease Pharm. Res. 2006, 23, 1417-1450 (Pubitemid 43993807)
15. Sukhorukov, G. B.; Rogach, A. L.; Zebli, B.; Liedl, T.; Skirtach, A. G.; Köhler, K.; Antipov, A. A.; Gaponik, N.; Susha, A. S.; Winterhalter, M. et al. Nanoengineered Polymer Capsules: Tools for Detection, Controlled Delivery, and Site-Specific Manipulation Small 2005, 1, 194-200 (Pubitemid 43958456)
16. Zhang, F.; Lees, E.; Amin, F.; RiveraGil, P.; Yang, F.; Mulvaney, P.; Parak, W. J. Polymer-Coated Nanoparticles: A Universal Tool for Biolabelling Experiments Small 2011, 7, 3113-3127
17. Sperling, R. A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W. J. Biological Applications of Gold Nanoparticles Chem. Soc. Rev. 2008, 37, 1896-1908
18. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R. N. Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications Chem. Rev. 2008, 108, 2064-2110
19. Kelkar, S. S.; Reineke, T. M. Theranostics: Combining Imaging and Therapy Bioconjugate Chem. 2011, 22, 1879-1903
20. Barraud, L.; Merle, P.; Soma, E.; Lefrançois, L.; Guerret, S.; Chevallier, M.; Dubernet, C.; Couvreur, P.; Trépo, C.; Vitvitski, L. Increase of Doxorubicin Sensitivity by Doxorubicin-Loading into Nanoparticles for Hepatocellular Carcinoma Cells in Vitro and in Vivo J. Hepatol. 2005, 42, 736-743
21. Fattal, E.; Youssef, M.; Couvreur, P.; Andremont, A. Treatment of Experimental Salmonellosis in Mice with Ampicillin-Bound Nanoparticles Antimicrob. Agents Chemother. 1989, 33, 1540-1543 (Pubitemid 19228010)
22. Calvo, P.; Gouritin, B.; Villarroya, H.; Eclancher, F.; Giannavola, C.; Klein, C.; Andreux, J. P.; Couvreur, P. Quantification and Localization of Pegylated Polycyanoacrylate Nanoparticles in Brain and Spinal Cord During Experimental Allergic Encephalomyelitis in the Rat Eur. J. Neurosci. 2002, 15, 1317-1326 (Pubitemid 35477993)
23. Reddy, L. H.; Couvreur, P. Nanotechnology for Therapy and Imaging of Liver Diseases J. Hepatol. 2011, 55, 1461-1466
24. Peracchia, M. T.; Desmaële, D.; Couvreur, P.; d'Angelo, J. Synthesis of a Novel Poly(MePEG cyanoacrylate- co -alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology Macromolecules 1997, 30, 846-851 (Pubitemid 127567687)
25. Calvo, P.; Gouritin, B.; Chacun, H.; Desmaele, D.; D'Angelo, J.; Noel, J. P.; Georgin, D.; Fattal, E.; Andreux, J. P.; Couvreur, P. Long-Circulating Pegylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery Pharm. Res. 2001, 18, 1157-1166 (Pubitemid 32900402)
26. Brigger, I.; Morizet, J.; Aubert, G.; Chacun, H.; Terrier-Lacombe, M. J.; Couvreur, P.; Vassal, G. Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting J. Pharmacol. Exp. Ther. 2002, 303, 928-936 (Pubitemid 35424373)
27. Nicolas, J.; Couvreur, P. Synthesis of Poly(alkyl cyanoacrylate)-Based Colloidal Nanomedicines Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1, 111-127
28. Müller, R. H.; Lherm, C.; Herbort, J.; Couvreur, P. In Vitro Model for the Degradation of Alkylcyanoacrylate Nanoparticles Biomaterials 1990, 11, 590-595 (Pubitemid 20367837)
29. Low, P. S.; Henne, W. A.; Doorneweerd, D. D. Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases Acc. Chem. Res. 2008, 41, 120-129
30. Lu, Y.; Low, P. S. Folate-Mediated Delivery of Macromolecular Anticancer Therapeutic Agents Adv. Drug Delivery Rev. 2002, 54, 675-693 (Pubitemid 35247522)
31. Lu, Y.; Sega, E.; Leamon, C. P.; Low, P. S. Folate Receptor-Targeted Immunotherapy of Cancer: Mechanism and Therapeutic Potential Adv. Drug Delivery Rev. 2004, 56, 1161-1176 (Pubitemid 38496513)
32. Lee, E. S.; Na, K.; Bae, Y. H. Super pH-Sensitive Multifunctional Polymeric Micelle Nano Lett. 2005, 5, 325-329 (Pubitemid 40308294)
33. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions Angew. Chem., Int. Ed. 2001, 40, 2004-2021
34. Brambilla, D.; Nicolas, J.; Le Droumaguet, B.; Andrieux, K.; Marsaud, V.; Couraud, P.-O.; Couvreur, P. Design of Fluorescently Tagged Poly(alkyl cyanoacrylate) Nanoparticles for Human Brain Endothelial Cell Imaging Chem. Commun. 2010, 46, 2602-2604
35. Russell-Jones, G.; McTavish, K.; McEwan, J.; Rice, J.; Nowotnik, D. Vitamin-Mediated Targeting as a Potential Mechanism to Increase Drug Uptake by Tumours J. Inorg. Biochem. 2004, 98, 1625-1633 (Pubitemid 39349188)
36. Kelloff, G. J.; Crowell, J. A.; Hawk, E. T.; Steele, V. E.; Lubet, R. A.; Boone, C. W.; Covey, J. M.; Doody, L. A.; Omenn, G. S.; Greenwald, P. et al. Strategy and Planning for Chemopreventive Drug Development: Clinical Development Plans II J. Cell. Biochem. 1996, 63, 54-71 (Pubitemid 27203752)
37. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism Chem. Biol. Drug Des. 2006, 67, 27-37 (Pubitemid 43881385)
38. Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin Has Potent Anti-amyloidogenic Effects for Alzheimer's B-Amyloid Fibrils in Vitro J. Neurosci. Res. 2004, 75, 742-750 (Pubitemid 38296087)
39. Yang, F.; Lim, G. P.; Begum, A. N.; Ubeda, O. J.; Simmons, M. R.; Ambegaokar, S. S.; Chen, P. P.; Kayed, R.; Glabe, C. G.; Frautschy, S. A. et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo J. Biol. Chem. 2005, 280, 5892-5901 (Pubitemid 40280072)
40. Reinke, A. A.; Gestwicki, J. E. Structure-Activity Relationships of Amyloid Beta-Aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility Chem. Biol. Drug Des. 2007, 70, 206-215 (Pubitemid 47305405)
41. Thielbeer, F.; Donaldson, K.; Bradley, M. Zeta Potential Mediated Reaction Monitoring on Nano and Microparticles Bioconjugate Chem. 2011, 22, 144-150
42. Ouberai, M.; Dumy, P.; Chierici, S.; Garcia, J. Synthesis and Biological Evaluation of Clicked Curcumin and Clicked Klvffa Conjugates as Inhibitors of B-Amyloid Fibril Formation Bioconjugate Chem. 2009, 20, 2123-2132
43. Shi, W.; Dolai, S.; Rizk, S.; Hussain, A.; Tariq, H.; Averick, S.; L'Amoreaux, W.; El Idrissi, A.; Banerjee, P.; Raja, K. Synthesis of Monofunctional Curcumin Derivatives, Clicked Curcumin Dimer, and a Pamam Dendrimer Curcumin Conjugate for Therapeutic Applications Org. Lett. 2007, 9, 5461-5464
44. Mourtas, S.; Canovi, M.; Zona, C.; Aurilia, D.; Niarakis, A.; La Ferla, B.; Salmona, M.; Nicotra, F.; Gobbi, M.; Antimisiaris, S. G. Curcumin-Decorated Nanoliposomes with Very High Affinity for Amyloid-B1-42 Peptide Biomaterials 2011, 32, 1635-1645
45. Brambilla, D.; Verpillot, R.; Taverna, M.; De Kimpe, L.; Le Droumaguet, B.; Nicolas, J.; Mantegazza, F.; Canovi, M.; Gobbi, M.; Salmona, M. et al. Capillary Electrophoresis with Laser-Induced Fluorescence Detection (Ce-Lif) as a New Protocol to Monitor Interaction between Nanoparticles and the Amyloid-B Peptide Anal. Chem. 2010, 82, 10083-10089
46. Wang, Y.-J.; Pan, M.-H.; Cheng, A.-L.; Lin, L.-I.; Ho, Y.-S.; Hsieh, C.-Y.; Lin, J.-K. Stability of Curcumin in Buffer Solutions and Characterization of Its Degradation Products J. Pharm. Biomed. Anal. 1997, 15, 1867-1876 (Pubitemid 27341993)
47. Airoldi, C.; Zona, C.; Sironi, E.; Colombo, L.; Messa, M.; Aurilia, D.; Gregori, M.; Masserini, M.; Salmona, M.; Nicotra, F. et al. Curcumin Derivatives as New Ligands of Aβ Peptides J. Biotechnol. 2011, 156, 317-324
48. Gobbi, M.; Re, F.; Canovi, M.; Beeg, M.; Gregori, M.; Sesana, S.; Sonnino, S.; Brogioli, D.; Musicanti, C.; Gasco, P. et al Lipid-Based Nanoparticles with High Binding Affinity for Amyloid-B1-42 Peptide Biomaterials 2010, 31, 6519-6529
49. Canovi, M.; Markoutsa, E.; Lazar, A. N.; Pampalakis, G.; Clemente, C.; Re, F.; Sesana, S.; Masserini, M.; Salmona, M.; Duyckaerts, C. et al. The Binding Affinity of Anti-Aβ1-42 mab-Decorated Nanoliposomes to Aβ1-42 peptides in Vitro and to Amyloid Deposits in Postmortem Tissue Biomaterials 2011, 32, 5489-5497
50. Qi, K.; Ma, Q.; Remsen, E. E.; Clark, C. G., Jr.; Wooley, K. L. Determination of the Bioavailability of Biotin Conjugated onto Shell Crosslinked Nanoparticles J. Am. Chem. Soc. 2004, 126, 6599-6607 (Pubitemid 38701760)
51. Brambilla, D.; Verpillot, R.; Le Droumaguet, B.; Nicolas, J.; Taverna, M.; Kóňa, J.; Lettiero, B.; Hashemi, S. H.; De Kimpe, L.; Canovi, M. et al. Pegylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer's Disease ACS Nano 2012, 10.1021/nn300489k
52. Nicolas, J.; Bensaid, F.; Desmaele, D.; Grogna, M.; Detrembleur, C.; Andrieux, K.; Couvreur, P. Synthesis of Highly Functionalized Poly(alkyl cyanoacrylate) Nanoparticles by Means of Click Chemistry Macromolecules 2008, 41, 8418-8428
53. Beeg, M.; Stravalaci, M.; Bastone, A.; Salmona, M.; Gobbi, M. A Modified Protocol to Prepare Seed-Free Starting Solutions of Amyloid-B (Aβ)1-40 and Aβ1-42 from the Corresponding Depsipeptides Anal. Biochem. 2011, 411, 297-299